daiichisankyo.us

Website review daiichisankyo.us

Passion for innovation. Compassion for patients.- Daiichi Sankyo US

 Generated on March 12 2026 17:06 PM

Old data? UPDATE !

The score is 54/100

SEO Content

Title

Passion for innovation. Compassion for patients.- Daiichi Sankyo US

Length : 67

Perfect, your title contains between 10 and 70 characters.

Description

Learn about who we are, our approach to scientific innovation, our areas of therapeutic focus, our products, commitments and more.

Length : 130

Great, your meta description contains between 70 and 160 characters.

Keywords

home, homepage, landing

Good, your page contains meta keywords.

Og Meta Properties

Good, your page take advantage of Og Properties.

Property Content
description Learn about who we are, our approach to scientific innovation, our areas of therapeutic focus, our products, commitments and more.
locale en_US
locale:alternate en_US
site_name DSI
title Passion for innovation. Compassion for patients.
type website
url https://daiichisankyo.us

Headings

H1 H2 H3 H4 H5 H6
1 34 0 0 0 0
  • [H1] Passion for Innovation. Compassion for Patients.®
  • [H2] Search Bar
  • [H2] Menu Display
  • [H2] Who We Are
  • [H2] Strategy
  • [H2] Purpose
  • [H2] Partners
  • [H2] Leadership
  • [H2] History
  • [H2] Patient Advocacy
  • [H2] Our Crafts
  • [H2] Compliance +
  • [H2] Transparency and Disclosure +
  • [H2] Corporate Grants and Giving +
  • [H2] Daiichi Sankyo Patient Support Programs
  • [H2] Supplier Diversity +
  • [H2] Transparency in Coverage
  • [H2] Rights & Protections Against Surprise Medical Bills
  • [H2] Our Science
  • [H2] Our Pipeline
  • [H2] Worldwide R&D Operations
  • [H2] Clinical Trial Information Disclosure
  • [H2] Expanded Access to Investigational Products
  • [H2] External Sponsored Research (ESR) Investigator Initiated Studies (IIS) and Collaborative Research (CR)
  • [H2] Breadcrumb
  • [H2] Creating New Standards of Care
  • [H2] Our Stories
  • [H2] Asset Publisher
  • [H2] Transforming Science into Medicines
  • [H2] Striving to Create Optimized Antibody Drug Conjugate (ADC) Technology
  • [H2] What's New
  • [H2] Asset Publisher
  • [H2] A Pipeline Pushing Us to Become a Global Leader in Oncology
  • [H2] Work with a Purpose
  • [H2] Menu Display

Images

We found 12 images on this web page.

1 alt attributes are empty or missing. Add alternative text so that search engines can better understand the content of your images.

Text/HTML Ratio

Ratio : 37%

Ideal! This page's ratio of text to HTML code is between 25 and 70 percent.

Flash

Perfect, no Flash content has been detected on this page.

Iframe

Too Bad, you have Iframes on the web pages, this mean that content in an Iframe cannot be indexed.

URL Rewrite

Good. Your links looks friendly!

Underscores in the URLs

We have detected underscores in your URLs. You should rather use hyphens to optimize your SEO.

In-page links

We found a total of 61 links including 0 link(s) to files

Anchor Type Juice
Skip to content Internal Passing Juice
Healthcare Professionals External Passing Juice
Careers Internal Passing Juice
Contact Us Internal Passing Juice
Worldwide External Passing Juice
About Us Internal Passing Juice
Who We Are Internal Passing Juice
Strategy Internal Passing Juice
Purpose Internal Passing Juice
Partners Internal Passing Juice
Leadership Internal Passing Juice
History Internal Passing Juice
Patient Advocacy Internal Passing Juice
Our Crafts Internal Passing Juice
Compliance Internal Passing Juice
Standards Of Business Conduct Internal Passing Juice
Standards of Business Conduct & Ethics for Third Parties Internal Passing Juice
Daiichi Sankyo Group Global Anti-Bribery and Anti-Corruption Policy Internal Passing Juice
California Compliance Declaration Internal Passing Juice
California Supply Chains Act Internal Passing Juice
Daiichi Sankyo Group Employee Code of Conduct Internal Passing Juice
Transparency and Disclosure Internal Passing Juice
Post-marketing Commitments Internal Passing Juice
Working with Healthcare Professionals Internal Passing Juice
Vermont Pharmaceutical Marketer Price Disclosure Internal Passing Juice
Clinical Trial Information Disclosure External Passing Juice
Corporate Grants and Giving Internal Passing Juice
Independent Grants Internal Passing Juice
Sponsorships Internal Passing Juice
Charitable Contributions Internal Passing Juice
Daiichi Sankyo Requirements Internal Passing Juice
Corporate Support FAQs Internal Passing Juice
Daiichi Sankyo Patient Support Programs Internal Passing Juice
Supplier Diversity Internal Passing Juice
Supplier Registration Internal Passing Juice
Supplier Diversity FAQs Internal Passing Juice
Transparency in Coverage Internal Passing Juice
Rights & Protections Against Surprise Medical Bills Internal Passing Juice
Our Science Internal Passing Juice
Our Pipeline External Passing Juice
Worldwide R&D Operations External Passing Juice
Expanded Access to Investigational Products External Passing Juice
External Sponsored Research (ESR) Investigator Initiated Studies (IIS) and Collaborative Research (CR) External Passing Juice
Medicines Internal Passing Juice
Media Internal Passing Juice
Our Stories Internal Passing Juice
Home Internal Passing Juice
Learn More About Our Purpose Internal Passing Juice
View More Stories Internal Passing Juice
HER2 in Gynecologic Cancers—Why It Matters Internal Passing Juice
Showing Up for Patients: CARE Teams Inspire Hope in Their Communities Internal Passing Juice
Learn More About Our Science Internal Passing Juice
Explore the DXd ADC Technology Website External Passing Juice
View More News Internal Passing Juice
Patent Dispute Between Daiichi Sankyo and Seagen has Concluded Internal Passing Juice
ENHERTU Granted Priority Review in the US as Post-Neoadjuvant Treatment for Patients with HER2 Positive Early Breast Cancer Internal Passing Juice
Learn More About Our Medicines Internal Passing Juice
Terms & Conditions Internal Passing Juice
Privacy Notice Internal Passing Juice
Site Map Internal Passing Juice
Return External Passing Juice

SEO Keywords

Keywords Cloud

dose count cancer adverse metastatic decreased treatment patients reactions enhertu

Keywords Consistency

Keyword Content Title Keywords Description Headings
patients 159
enhertu 159
decreased 89
adverse 60
count 55

Usability

Url

Domain : daiichisankyo.us

Length : 16

Favicon

Great, your website has a favicon.

Printability

We could not find a Print-Friendly CSS.

Language

Good. Your declared language is en.

Dublin Core

This page does not take advantage of Dublin Core.

Document

Doctype

HTML 5

Encoding

Perfect. Your declared charset is UTF-8.

W3C Validity

Errors : 0

Warnings : 0

Email Privacy

Warning! At least one email address has been found in the plain text. Use free antispam protector to hide email from spammers.

Deprecated HTML

Great! We haven't found deprecated HTML tags in your HTML.

Speed Tips

Excellent, your website doesn't use nested tables.
Too bad, your website is using inline styles.
Too bad, your website has too many CSS files (more than 4).
Too bad, your website has too many JS files (more than 6).
Too bad, your website does not take advantage of gzip.

Mobile

Mobile Optimization

Apple Icon
Meta Viewport Tag
Flash content

Optimization

XML Sitemap

Great, your website has an XML sitemap.

https://daiichisankyo.us/sitemap.xml

Robots.txt

https://daiichisankyo.us/robots.txt

Great, your website has a robots.txt file.

Analytics

Great, your website has an analytics tool.

   Google Analytics

PageSpeed Insights

Device
Categories

Free SEO Testing Tool

Free SEO Testing Tool is a free SEO tool which provides you content analysis of the website.